Today: 21 May 2026

Amazon stock slips near close as AWS chip pact spotlights $200B AI spending bet

Amazon stock slips near close as AWS chip pact spotlights $200B AI spending bet

Amazon shares fell 0.5% to $209.19 Monday as investors weighed the company’s expanded chip deal with STMicroelectronics and a projected $200 billion in 2026 capital spending. AWS secured rights to buy up to 24.8 million ST shares over seven years, tied to chip purchases. About 80.8 million Amazon shares traded. U.S. jobs and inflation data due later this week could affect tech valuations.
9 February 2026
·····
Micron stock drops after-hours as Samsung HBM4 report rattles Nvidia supply bets

Micron stock drops after-hours as Samsung HBM4 report rattles Nvidia supply bets

Micron shares fell 2.9% to $383.24 in after-hours trading Monday amid reports Samsung will begin mass production and shipment of HBM4 memory for Nvidia’s upcoming “Vera Rubin” AI chips. Industry sources say Samsung passed Nvidia’s quality checks, while SK hynix and Micron are expected to split the rest of early supply. No official confirmation on volumes.
9 February 2026
···
Tesla stock rises as robotaxi race heats up — what TSLA investors watch next

Tesla stock rises as robotaxi race heats up — what TSLA investors watch next

Tesla shares closed up 2.2% at $420.18 Monday, tracking gains in U.S. tech stocks. Alphabet’s Waymo announced fully autonomous operations in Nashville, intensifying the robotaxi race. Investors await U.S. payrolls and inflation data for rate signals. Tesla’s focus remains on autonomy, with Cybercab production targeted for this year.
9 February 2026
·····
Nebius Group (NBIS) stock price jumps 8% as earnings week sharpens focus on AI cloud buildout

Nebius Group (NBIS) stock price jumps 8% as earnings week sharpens focus on AI cloud buildout

Nebius Group N.V. shares jumped 8.3% to $93.26 in heavy trading Monday, ahead of its quarterly results due Feb. 12. The Amsterdam-based AI cloud firm’s stock swung sharply as investors weighed execution risks on major GPU infrastructure contracts with Meta and Microsoft. Wall Street expects another loss, with consensus at a 44-cent per-share deficit on $232.2 million in revenue.
9 February 2026
·····
BlackRock stock price jumps as Deutsche Bank plugs HausFX into Aladdin

BlackRock stock price jumps as Deutsche Bank plugs HausFX into Aladdin

BlackRock shares climbed 2.5% to $1,083.31 in late trading Monday after the company announced an Aladdin-HausFX integration with Deutsche Bank to automate FX workflows. The firm also reorganized seven municipal closed-end funds into three, adopting a discount management program. Investors are watching for CFO Martin Small’s appearance Tuesday and key U.S. economic data later this week.
9 February 2026
·····
PayPal stock price rebounds as Cantor slashes target and Wall Street looks to CEO handover

PayPal stock price rebounds as Cantor slashes target and Wall Street looks to CEO handover

PayPal shares rose 1.7% to $41.12 Monday after Cantor Fitzgerald cut its 12-month price target to $42 and maintained a neutral rating. The move follows last week’s leadership shakeup, with Enrique Lores set to take over as CEO March 1. PayPal’s recent earnings missed estimates, and branded checkout growth slowed amid tougher competition. Investors remain uncertain about the company’s turnaround prospects.
9 February 2026
·
Amgen stock drops nearly 2% as Dow drag builds — what AMGN investors watch next

Amgen stock drops nearly 2% as Dow drag builds — what AMGN investors watch next

Amgen shares dropped 1.8% to $377.28 in mid-afternoon trading Monday, weighing on the Dow Jones Industrial Average. The decline followed news of an FDA request to withdraw rare-disease drug Tavneos and a sharp 48% fall in Enbrel sales last quarter. Broader drug stocks lagged while traders awaited key U.S. jobs and inflation data later in the week.
9 February 2026
····
Coca-Cola stock price slips despite Wells Fargo target hike as KO earnings loom

Coca-Cola stock price slips despite Wells Fargo target hike as KO earnings loom

Coca-Cola shares fell 1.2% to $78.08 Monday as consumer staples lagged a tech-led rebound. Wells Fargo raised its price target on Coca-Cola to $87, maintaining an “overweight” rating ahead of Tuesday’s earnings. Investors await signals on demand and pricing, with options traders bracing for a 3% swing. Broader markets focused on upcoming U.S. jobs and inflation data.
9 February 2026
··
Teradyne stock rises as chip-test names rebound; traders scan downgrades and U.S. data

Teradyne stock rises as chip-test names rebound; traders scan downgrades and U.S. data

Teradyne shares climbed 3.3% to $309.95 in Monday afternoon trading, following a volatile session and a 60% gain year-to-date. President Capital Management downgraded the stock to neutral but raised its price target to $308. Investors await U.S. jobs and inflation data later this week, which could affect rate-cut expectations. Teradyne’s next dividend record date is February 13.
9 February 2026
··
Coherent Corp stock jumps 7% after BofA lifts target to $250 as AI data-center spending stays in focus

Coherent Corp stock jumps 7% after BofA lifts target to $250 as AI data-center spending stays in focus

Coherent Corp shares jumped 7.2% to $244.13 Monday after Bank of America raised its price target to $250, maintaining a Neutral rating. The move followed volatile trading after earnings and comes as investors focus on AI-driven optical demand and upcoming U.S. inflation data. Other optical stocks also gained. Coherent forecast third-quarter revenue of $1.70–$1.84 billion and non-GAAP EPS of $1.28–$1.48.
9 February 2026
····
Applied Digital stock jumps nearly 10% as AI data-center trade rebounds; what’s next for APLD

Applied Digital stock jumps nearly 10% as AI data-center trade rebounds; what’s next for APLD

Applied Digital shares jumped 9.6% to $38.32 Monday afternoon, swinging between $33.48 and $39.33 on heavy volume. No new company news was posted. About a third of the float was sold short as of mid-January, heightening volatility. Traders are eyeing U.S. payrolls and CPI data later this week for further market direction.
9 February 2026
···
1 … 296 297 298 299 300 … 1,961

Stock Market Today

  • Analyst Revises MongoDB Outlook After Sharp 22% Stock Decline
    May 20, 2026, 11:08 PM EDT. An analyst shifted to a more favorable view on MongoDB (NASDAQ: MDB) after its stock plunged 22% on March 3, 2026, despite better-than-expected fiscal Q4 results. The company reported $695 million revenue, up 27% year-over-year, with Atlas cloud revenue hitting a $2 billion annual run rate. However, cautious fiscal 2027 guidance projecting 16-18% revenue growth-below expectations-triggered the drop and a Baird price target cut from $500 to $260. The analyst now highlights MongoDB's strong business fundamentals, including a 23% adjusted operating margin and leading position in document databases, which support cloud-native applications. The initial high valuation and AI premium correction have shifted risk perceptions, revealing a steadier business amid recent market volatility.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop